Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ONTO INNOVATION INC. Director's Dealing 2011

Feb 16, 2011

30874_dirs_2011-02-16_6c04a95d-da26-43fb-b839-588fc6282a09.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NANOMETRICS INC (NANO)
CIK: 0000704532
Period of Report: 2011-02-14

Reporting Person: Coates Norman V (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2011-02-14 Common Stock S 50000 $17.5403 Disposed 1632460 Indirect
2011-02-15 Common Stock S 1166 $17.4422 Disposed 2886 Direct
2011-02-15 Common Stock M 2038 $11.17 Acquired 4924 Direct
2011-02-15 Common Stock S 2038 $17.49 Disposed 2886 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2011-02-15 Non-Qualified Stock Option (right to buy) $11.17 M 2038 Disposed 2017-01-04 Common Stock (2038) Direct

Footnotes

F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Vincent J. Coates Separate Property Trust on February 23, 2010.

F2: The price in Column 4 is a weighted average sale price. The prices actually received ranged from $17.32 to $17.75. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

F3: Shares held of record by the Vincent J. Coates Separate Property Trust, U/D/T dated August 7, 1981, for which Norman Coates and Stella Coates act as co-trustees.

F4: The price in Column 4 is a weighted average sale price. The prices actually received ranged from $17.4400 to $17.4445. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

F5: The option became exercisable on January 4, 2011, the first anniversary of the date of grant.